Inventor · disambiguated record
Nancy Labbe-Giguere
Also filed as: LABBE-GIGUERE NANCY
6 granted patents·4 pending applications·6 citations·filing 2020–2024
73Inventor score
Files withNOVARTIS AG10
Top patents by PatentIndex Score
10 records- 0191US11708366B2Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2021·Granted Jul 25, 2023·2 cites·27 claims
- 0290US11485742B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Nov 1, 2022·2 cites·22 claims
- 0389US11548865B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Jan 10, 2023·2 cites·29 claims
- 0479US2025092042A1Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0577US12157737B2Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2023·Granted Dec 3, 2024·0 cites·16 claims
- 0677US2024140959A12-azaspiro[3.4]octane derivatives as m4 agonistsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0774US11820778B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Nov 21, 2023·0 cites·30 claims
- 0870US12122761B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Oct 22, 2024·0 cites·25 claims
- 0962US2025223277A1Complement factor b inhibitors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1061US2025115572A1Spirocyclic piperidinyl derivatives as complement factor b inhibitors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nancy Labbe-Giguere files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →